These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24308772)

  • 1. Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions.
    Hussey GS; Goehring LS; Lunn DP; Hussey SB; Huang T; Osterrieder N; Powell C; Hand J; Holz C; Slater J
    Vet Res; 2013 Dec; 44(1):118. PubMed ID: 24308772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.
    Pusterla N; Dorman DC; Burgess BA; Goehring L; Gross M; Osterrieder K; Soboll Hussey G; Lunn DP
    J Vet Intern Med; 2024; 38(3):1765-1791. PubMed ID: 38069548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
    Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the role of mules as silent shedders of EHV-1 during an outbreak of EHV-1 myeloencephalopathy in California.
    Pusterla N; Mapes S; Wademan C; White A; Estell K; Swain E
    Vet Rec; 2012 May; 170(18):465. PubMed ID: 22472540
    [No Abstract]   [Full Text] [Related]  

  • 7. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak.
    Traub-Dargatz JL; Pelzel-McCluskey AM; Creekmore LH; Geiser-Novotny S; Kasari TR; Wiedenheft AM; Bush EJ; Bjork KE
    J Vet Intern Med; 2013; 27(2):339-46. PubMed ID: 23398291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
    Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
    Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?
    Hussey GS; Giessler KS
    Vet J; 2022 Apr; 282():105827. PubMed ID: 35405348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
    Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
    J Virol; 2024 Jun; 98(6):e0025024. PubMed ID: 38742875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation parameters following equine herpesvirus type 1 infection in horses.
    Wilson ME; Holz CL; Kopec AK; Dau JJ; Luyendyk JP; Soboll Hussey G
    Equine Vet J; 2019 Jan; 51(1):102-107. PubMed ID: 29658149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
    Allen GP; Breathnach CC
    Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine herpesvirus 1 myeloencephalopathy.
    Pusterla N; Hussey GS
    Vet Clin North Am Equine Pract; 2014 Dec; 30(3):489-506. PubMed ID: 25300635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of a quantitative PCR assay to study equine herpesvirus 5 invasion and replication in equine tissues in vitro and in vivo.
    Zarski LM; High EA; Nelli RK; Bolin SR; Williams KJ; Hussey G
    J Virol Methods; 2017 Oct; 248():44-53. PubMed ID: 28455133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.